Grant projects – fostering innovation and collaboration 

CD20 CAR-TIME
CD20 CAR transduced T cells for individualized melanoma therapy 
Fkz 01EK1507A 


ART4Fun
Antigen reactive T cells for diagnosis and therapy of fungus-associated diseases in high-risk patients
Fkz 03ZZ0813F
 

iCARE 
Induced pluripotent stem cells for cellular therapy of cardiac diseases
Fkz 01EK1601D
 

iPStemRNA 
Generation of GMP-compliant induced pluripotent stem cells from universal donors. 
Sub-project: Development of prototypes and material for GMP-compliant production of iPS cells 
Fkz 01EK1610C 
 

ReSight
Generation of transplantable hiPSC-derived retinal cells for treatment of retinal degeneration 
Fkz 01EK1613C 
 

ELICIT
Advanced confocal light sheet microscopy for clinical high-throughput analysis of immune cell infiltration of tumor samples. 
Sub-project: Development, verification and adaptation of specific probes for light sheet microscopy 
Fkz 13N14347  

PROCROP
Professional cross-priming for ovary and prostate cancer 
GA 635122
 

SCIDNET
Developing Genetic medicines for Severe Combined Immunodeficiency 
GA 666908
 

CARAT 
Chimeric Antigen Receptors for Advanced Therapies 
GA 667980
 

PIX4LIFE
Silicon Nitride Photonic Integrated Circuit Pilot line for Life Science Applications in the Visible Range 
GA 688519
 

Trace 
Transfer of multivirus-specific T-cells following transplantation 
GA 755005
 

MATURE-NK 
Manufacturing of Tumour-Reactive Natural Killer cells 
GA 765104
 

EUROoC 
Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe 
GA 812954
 

ENDONANO
Quantitative detection of bacterial endotoxin by novel nanotechnological approaches 
GA 812661 

Mecklenburg-West Pomerania

PiCoP 
Peptide-based immunization strategies for Colon and Pancreas carcinomas
TBI-V-1-243-VBU-085
 

MACS-MS
Analysis of biomarkers for the detection of apheresis responders and glucocorticosteroid responders in multiple sclerosis patients with acute disease relapse 
TBI-V-1-269-VBU-095 

North Rhine Westfalia

iCAN33 
Development of an immunotherapy for acute myeloid leukaemias (AMLs) using allogeneic natural killer (NK) cells with CD33 CARs 
LS-2-1-018g 
 

ImmunePredict 
Development of new predictive markers for response to immune checkpoint inhibitors of solid tumors 
LS-2-1-002b 
 

TraCAR
Non-invasive imaging of pharmacokinetics and optimisation of CAR T-cell therapies of solid tumours
LS-2-2-050a
 

CardioPatch
Vascularised, bioartificial heart muscle from induced pluripotent stem cells
LS-2-2-029f